CAV Regimen for R/R Ph- B-ALL

Abroad (travel likely)Recruiting

Conditions

Acute Lymphoblastic Leukemia

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
Contact: Study coordinator (Sheng-Li Xue, M.D.) · slxue@suda.edu.cn · +86 512 6778 1139

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Therapy for Newly Diagnosed Patients With B-Cell Precursor Acute Lymphoblastic Leukemia and Lymphoma

Acute Lymphoblastic Leukemia · Lymphoblastic Lymphoma

Abroad (travel likely)RecruitingPHASE2

Charlotte, United States · Tulsa, United States

Inotuzumab Ozogamicin in Treating Younger Patients With B-Lymphoblastic Lymphoma or Relapsed or Refractory CD22 Positive B Acute Lymphoblastic Leukemia

Recurrent B Acute Lymphoblastic Leukemia · Recurrent B Lymphoblastic Lymphoma · Refractory B Acute Lymphoblastic Leukemia

Abroad (travel likely)RecruitingPHASE2

Birmingham, United States · Anchorage, United States

ONC201 in Treating Patients With Relapsed or Refractory Acute Leukemia or High-Risk Myelodysplastic Syndrome

Recurrent Acute Lymphoblastic Leukemia · Recurrent Acute Myeloid Leukemia · Recurrent Myelodysplastic Syndrome

Abroad (travel likely)RecruitingPHASE1, PHASE2

Houston, United States

Study of AZD4512 Monotherapy or in Combination With Anticancer Agents in Participants With Acute Lymphoblastic Leukemia

B-cell Acute Lymphoblastic Leukemia (B-ALL)

Abroad (travel likely)RecruitingPHASE1, PHASE2

Duarte, United States · Jacksonville, United States